- US FTC urges Congress to ban “pay-for-delay” deals (PharmaTimes)
- FDA panel backs Recordati’s NAGS deficiency drug (PharmaTimes)
- Swine Flu: False Pandemic? Questions In Europe (Medical News Today)
- Amgen Cancer Push on Bone Drug May Key Stock Turnaround in 2010 (Bloomberg)
- Europe Launches Probe into Pharma Deals (BusinessWeek)
- New Anti-Clotting Drug Outperforms Plavix (BusinessWeek)
- FDA letter cites Lilly for marketing (Associated Press)
- ARB blood pressure drugs reduce Alzheimer’s risk – study (PharmaTimes)
SUBSCRIBE